Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Dow
Cipla
Argus Health
Cantor Fitzgerald
US Army
Deloitte
Baxter
QuintilesIMS

Generated: April 27, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019591

« Back to Dashboard

NDA 019591 describes LARIAM, which is a drug marketed by Roche and is included in one NDA. Additional details are available on the LARIAM profile page.

The generic ingredient in LARIAM is mefloquine hydrochloride. There are six drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the mefloquine hydrochloride profile page.
Summary for 019591
Tradename:LARIAM
Applicant:Roche
Ingredient:mefloquine hydrochloride
Patents:0
Therapeutic Class:Antiparasitics
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 019591

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength250MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:May 2, 1989TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Medtronic
Johnson and Johnson
Teva
Cipla
Julphar
Farmers Insurance
AstraZeneca
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.